NDC Active Ingredient Dabrafenib Mesylate

List of the 2 NDC products with the active ingredient Dabrafenib Mesylate. Dabrafenib may be used alone or in combination with another medication (trametinib) to treat a type of skin cancer (melanoma). It is also used with trametinib to treat thyroid cancer and a type of lung cancer (non-small cell lung cancer-NSCLC). Dabrafenib works by slowing the growth of cancer cells.

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Product Type
0078-0681Tafinlar DabrafenibCapsuleOralNovartis Pharmaceuticals CorporationHuman Prescription Drug
0078-0682Tafinlar DabrafenibCapsuleOralNovartis Pharmaceuticals CorporationHuman Prescription Drug